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Abstract
Background: Sleep homeostasis is characterized by a positive correlation between sleep length and intensity with
the duration of the prior waking period. A causal role for brain-derived neurotrophic factor (BDNF) in sleep
homeostasis has been suggested, but the underlying mechanisms remain unclear. Cortistatin, a neuropeptide
expressed primarily in a subset of cortical GABAergic interneurons, is another molecule implicated in sleep
homeostasis.
Results: We confirmed that sleep deprivation leads to an increase in cortical cortistatin mRNA expression.
Disruption of activity-dependent BDNF expression in a genetically modified mouse line impairs both baseline levels
of cortistatin mRNA as well as its levels following sleep deprivation. Disruption of activity-dependent BDNF also
leads to a decrease in sleep time during the active (dark) phase.
Conclusion: Our studies suggest that regulation of cortistatin-expressing interneurons by activity-dependent BDNF
expression may contribute to regulation of sleep behavior.
Background
Sleep behavior is dependent on two processes; circadian
regulation as well as homeostatic regulation [1,2]. Circa-
dian regulation dictates the distribution of sleep and
waking over the 24-h cycle, while homeostatic regula-
tion tracks sleep need [3]. Sleep pressure is increased by
sleep deprivation (SD) and reduced by increased sleep-
ing [4,5]. It is believed that slow wave activity (SWA)
measured in the delta range of the electroencephalo-
gram (EEG) (1.0-4.0 Hz) is regulated homeostatically,
and it is hypothetically associated with synaptic plasticity
[6,7]. Little is known about the biological processes
responsible for sleep homeostasis - the sleep need as a
function of previous wakefulness.
A recent study provided a biological link between
synaptic plasticity in the cerebral cortex and sleep
homeostasis [8]. There is a positive correlation between
exploratory behavior during wakefulness, the induction
of plasticity related genes including BDNF, Arc, Homer
and NGFI-A in the cerebral cortex, and the extent of
SWA, a sensitive marker for sleep pressure and sleep
need [9]. A key follow-up study provided evidence that
the degree of brain-derived neurotrophic factor (BDNF)
expression during wakefulness is causally linked to the
extent of SWA in the subsequent rest period [10].
BDNF is widely expressed in the developing and mature
brain, and plays an important role in neuronal survival
and differentiation during development, and in synaptic
plasticity in the adult brain [11-13]. Both its gene tran-
scription and its secretion are strongly regulated by neuro-
nal activity [11,14,15]. During development, BDNF
facilitates maturation of cortical inhibition and promotes
t h em a t u r eG A B A e r g i cp h e n o t y p e[ 1 6 - 2 2 ] .I np a r t i c u l a r ,
fast-spiking parvalbumin-positive interneurons, which
highly express the cognate receptor for BDNF, TrkB, are
especially sensitive to BDNF signaling [16,23,24].
Cells expressing the neuropeptide cortistatin define a
subset of GABAergic interneurons, which are found in
highest abundance in the cerebral cortex and hippocam-
pus [25,26]. Cortistatin expression is rapidly upregulated
in the second week of rodent postnatal life [25]. Cortista-
tin-expressing cells partially co-localize with cells
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Previous studies showed that cortistatin may be preferen-
tially localized to neurons that are double-positive for cal-
bindin and parvalbumin [25]. Cortistatin is structurally
related to somatostatin, but has biological functions that
render it functionally distinct [27,28]. For example, in con-
trast to somatostatin, cortistatin enhances SWA and can
antagonize the effects of cholinergic signaling on cortical
excitability [28-30]. These previous studies have defined
cortistatin as one of few molecules known to influence
and correlate with sleep need.
In the present study, we show that a genetic manipu-
lation that leads to disruption of activity-dependent
BDNF expression results in impairments in sleep regula-
tion and behavior that are consistent with a deficit in
sleep homeostasis. In parallel, we show that this genetic
alteration leads to misregulation of cortistatin gene
expression. Our results suggest that BDNF regulation of
sleep homeostasis may, at least in part, be mediated via
activity-dependent BDNF regulation of a subpopulation
of cortistatin-expressing interneurons.
Results
Basal levels of Bdnf expression in resting condition and
after induced neuronal activity in BDNF-KIV animals
Bdnf gene transcription is driven by at least nine differ-
ent promoters, each of which drives transcription of a
short, 5’ non-coding exon, which is spliced to a 3’ com-
m o nc o d i n ge x o n[ 3 1 ] .W eh a v ep r e v i o u s l yg e n e r a t e da
knock-in transgenic mouse line where transcription of
Bdnf from promoter IV, the promoter most sensitive to
neuronal activity [32,33], is disrupted by inserting a
green fluorescent protein (GFP)-STOP cassette into the
Bdnf promoter IV locus (BDNF-KIV) [32]. In these
mice, transcriptional activity from promoter IV leads to
production of GFP in lieu of BDNF. We have previously
shown that the activity-dependent expression of BDNF
protein is nearly abolished in these mice [32]. The aim
of the present study was to determine whether activity-
dependent BDNF expression influences sleep behavior.
We first analyzed Bdnf mRNA in the medial prefrontal
cortex (mPFC) in the BDNF-KIV and their wild type
(WT) littermates in regular, resting housing conditions
without any manipulation. Surprisingly, we found that
in addition to complete disruption of promoter IV-dri-
ven transcription, there was a significant dampening of
basal Bdnf transcription, including transcription driven
by promoters I, II, III, VI, and IXa in the resting condi-
tion, whereas basal transcription driven by promoters V
and VIII was less affected (Figure 1A, WT-Ctrl versus
KIV-Ctrl). For measurement of promoter II activity we
analyzed transcript levels of the II-c variant. Since the
II-a and II-b transcripts are driven by the same
promoter, analyses of levels of these transcripts were
nearly identical to the results obtained for the II-c var-
iant except that their expression levels were significantly
lower (data not shown). The observed dampening of
transcription from alternative promoters likely results
from promoter interference by the phosphoglycerate
kinase (PGK) promoter. This PGK promoter was left
intact in the mutant genome to drive expression of a
neomycin selection cassette [32].
To confirm that activity-dependent Bdnf transcription
is truly disrupted in the BDNF-KIV mice despite dam-
pening of basal Bdnf expression, we measured levels of
individual Bdnf transcripts in response to electroconvul-
sive shock (ECS), a condition in which neuronal activity
is dramatically enhanced. As expected, in the WT mPFC,
transcription driven by promoter IV was increased by the
largest magnitude, while more moderate induction was
seen from promoters I, II, III, VI and IXa (Figure 1A). In
our experimental setup, levels of exon VII were so low
that accurate quantification was not possible (data not
shown). We further confirmed that no exon IV transcript
could be detected in the mutant animals either before or
after ECS (Figure 1A, KI-Ctrl versus KI-ECS, exon IV).
These results, together with previous findings of rela-
tively unaltered basal BDNF protein levels in the cortex
of BDNF-KIV [32], suggest that the BDNF-KIV line
remains an excellent tool to study the functional conse-
quences of activity-dependent BDNF expression,
although it cannot be claimed as promoter-IV specific.
Circadian regulation of Bdnf expression and effect of
sleep deprivation
Expression of BDNF has been shown to correlate with
sleep need in the rat where its levels rise in correlation
with the extent of wakefulness over the circadian day
[34]. To determine whether and to what extent activity-
dependent transcription contributes to circadian regula-
tion of Bdnf expression, we compared transcript levels at
the end of the active (dark, awake) period and at the end
of the rest (light, sleep) period in WT and BDNF-KIV
mPFC. Three observations were made. First, Bdnf tran-
scription from promoters I, II, III, IV and IXa increased
during wakefulness in the WT animals (Figure 1B, WT-
Sleep versus WT-active). Second, there was a decrease in
levels of exon I, II-c, III, V, VI and IXa transcripts at
the end of the rest cycle (sleep) in the mutant animals
(Figure 1B, WT-Sleep versus KIV-sleep). These data are
almost identical to those seen in our previous experiment
under resting conditions (Figure 1A, except promoter V),
suggesting similar interferen c em e c h a n i s m sb yt h eP G K
promoter are operative. Third, in addition to a complete
blockade of transcription induction from promoter IV
over the waking cycle, the difference in Bdnf transcript
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waking cycle was magnified from promoters I and IXa
(Figure 1B and Additional File 1, table S1).
The molecular and cellular effects that occur over the
course of a circadian waking session can be magnified
when animals are exposed to sleep deprivation (SD). To
gain insight into the role of individual Bdnf transcripts
in sleep behavior, we performed a similar transcript ana-
lysis in WT and BDNF-KIV animals after exposure to
12-hours of SD. Transcription from promoters I, II, III,
IV and IXa was increased in the WT mPFC, with pro-
moter I showing the most robust effect as demonstrated
by a 12-fold induction (Figure 2A, WT-Ctrl versus
WT-SD, exons I, II-c, III, IV and IXa). In addition, for
transcripts I and IXa the SD-induced increase in tran-
scription was significantly attenuated in the BDNFK-IV
animals (Figure 2A and Additional File 1, table S1), sug-
gesting that the magnitude of Bdnf induction from mul-
tiple promoters following SD is impaired in BDNF-KIV
when compared to WT mice (Figure 2A). This suggests
that in conjunction with the complete loss of promoter-
IV driven increases, the induction of Bdnf transcription
in response to SD is attenuated in the BDNF-KIV mice.
We followed up these experiments by determining the
effects of SD on BDNF protein expression in WT and
mutant animals. In agreement with our mRNA results
we found that there was a moderate decrease in the
baseline levels of BDNF protein expression in the
mutant animals, but that the induction of BDNF expres-
sion following SD was highly impaired in the mutant
animals (Figure 2B). Consistent with this result, our pre-
vious study demonstrated that the increase in BDNF
protein induced by high-K
+ in embryo-derived cultured
cortical neurons and that the in vivo increase in BDNF
protein induced by kainic acid in the frontal cortex was
completely abolished in BDNF-KIV mice [32]. Thus, the
impact of the PGK promoter on downregulation of tran-
scription from alternative Bdnf promoters may contri-
bute to the complete lack of BDNF protein induction in
response to multiple neuronal-activity manipulations.
Figure 1 Effect of neuronal activity on Bdnf transcripts. All data are presented as fold changes over level of WT-Ctrl for that exon.
(A). Relative expression levels of individual Bdnf transcripts at baseline (Ctrl) and after electroconvulsive shock (ECS) in the medial prefrontal
cortex (mPFC) of WT and BDNF-KIV mice (n = 3 each condition). (B). Relative levels of individual Bdnf transcripts at the end of the lights on, rest
cycle (Sleep) and at the end of the lights off, active cycle (Active) in WT and BDNF-KIV animals (n = 3 each group).
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suggest that the BDNF-KIV line is an ideal model to
study the impact of loss of activity-dependent BDNF
expression.
The genetic misregulation in these mutant animals is
fairly complex with disruption of all promoter IV-driven
activity as well as significant down-regulation from alter-
native promoters both at baseline and in response to
different conditions of increased neuronal activity.
Therefore, to better interpret our data, we sought to
understand the abundance of individual transcripts in
these different environmental conditions. A quantitative
analysis was conducted to determine the relative abun-
dance of individual Bdnf transcripts in WT animals
under baseline conditions (Figure 3A), after ECS (Figure
3B) and after SD (Figure 3C). As expected, we found
that under baseline conditions and after ECS, exon IV-
containing transcripts were the most abundant in the
frontal cortex (Figure 3A, 3B). In contrast, after 12-hour
SD, exon I-containing transcripts overtook exon IV-
containing transcripts to become the most abundant
(Figure 3C).
Dysregulation of cortistatin gene expression
The BDNF-KIV mice exhibit deficits in cortical inhibi-
tory transmission and a small, but significant reduction
in parvalbumin immunofluoresence in the mPFC [32].
We asked whether activity-dependent BDNF signaling
may influence the expression of the neuropeptide cortis-
tatin, which is expressed in a subset of cortical GABAer-
gic interneurons and has been implicated as a molecule
that correlates with sleep need and influences sleep
homeostasis [25,27,35]. We first examined the mRNA
expression levels of markers of inhibitory interneurons
including Gad1, as well as the genes that encode the
calcium-binding proteins parvalbumin, calbindin and
calretinin (Pvalb, Calb1 and Calb2, respectively). There
was no significant change in the mRNA expression
levels of these markers between WT and mutant ani-
mals either at baseline or following SD (Figure 4A, 4B,
4C and 4D).
Next we analyzed markers of several neuropeptides,
which have been shown to co-localize with, as well as to
define, specific sub-populations of cortical interneurons.
We found differences in the mRNA levels of the genes
encoding neuropeptide Y, somatostatin, cortistatin, sub-
stance P and corticotropin-releasing hormone binding-
protein (Npy, Sst, Cort, Tac1 and Crhbp, respectively),
with the most striking down-regulation in Cort expres-
sion (Figure 5A, 5B, 5C, 5D and 5E). Interestingly, Cort,
Tac1 and Crhbp show significant increases in expression
levels in response to SD (Figure 5C, 5D, 5E). Thus,
these results may characterize a subpopulation of corti-
cal interneurons that is particularly sensitive to activity-
dependent BDNF signaling and play a role in regulation
of sleep homeostasis.
Disruption of activity-dependent BDNF expression leads
to changes in sleep behavior
To determine the effect of blockade of activity-
dependent BDNF expression on sleep behavior, we used
automated home-cage monitoring to analyze the sleep-
wake cycle. BDNF-KIV animals exhibited a substantial
decrease in the total amount of time spent sleeping over
a complete 24 h period compared to WT animals
(Figure 6A). Analysis of an hour-by-hour activity plot
revealed that the decrease in total sleep time resulted
from less time spent sleeping during the active (dark)
phase as well as a substantial delay before mutant ani-
mals commence their rest cycle (Figure 6B).
Figure 2 Effect of sleep deprivation on Bdnf transcripts and protein levels. (A). Relative levels of individual Bdnf transcripts at baseline (Ctrl)
and after 12 h of sleep deprivation (SD) in WT and BDNF-KIV animals. Data are quantified and presented as in Figure 1 (n = 3 each condition).
(B). Levels of total BDNF protein at baseline (Ctrl) and after 12 h of sleep deprivation (SD) in WT and BDNF-KIV animals. Data is presented at %
induction over WT-Ctrl (n = 4 each group).
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reported discrete breaks of inactivity in circadian wheel
running during the dark (active) period [36-39]. These
data have contributed to the idea that mice take a noc-
turnal nap during their active phase, a phenomena
coined “siesta sleeping”, as a means to discharge accu-
mulated sleep pressure [40-42]. Consistent with these
reports, we were able to detect this “siesta sleep” in WT
mice with home cage monitoring when animals were
observed under conditions of constant darkness. Under
constant darkness conditions, two distinct peaks of sleep
behavior during the active phase were revealed in WT
animals. However, no such peaks were observed in the
BDNF-KIV animals (Figure 6C). These results raise the
possibility that activity-dependent BDNF expression may
also be important in regulation of “siesta sleep”.
Discussion
We report here that BDNF-KIV mice slept less overall
than WT mice. This decrease was accounted for by less
sleep in the later parts of the active (dark) cycle and a
delay in entering the rest phase. With progression of the
active cycle or in response to SD, both Bdnf and Cort
expression increase as sleep pressure builds. Consistent
with this notion, we observed a rise in both Bdnf and
Cort gene expression in WT animals after exposure to
SD. However, in BDNF-KIV animals the levels of BDNF
mRNA and protein as well as Cort gene expression were
impaired. The genetic manipulation in the BDNF-KIV
animals results in complete disruption of promoter IV-
derived BDNF and down-regulation of additional Bdnf
transcripts, resulting in a complete loss of the SD-
induced increase in BDNF protein expression. Interest-
ingly, transcription driven by promoter I was the most
highly regulated in response to SD. In comparison to
the 2-fold increase in promoter IV-driven transcription,
promoter I driven transcription was elevated 12-fold.
This difference is quite striking compared to the effects
of ECS, which enhanced promoter IV activity by ~3-fold
and promoter I activity by ~2-fold. Indeed, following
SD, exon I-containing transcripts became the most
highly expressed in the mPFC, with exon I-containing
transcripts being expressed 4-fold more abundantly than
Figure 3 Relative abundance of individual Bdnf transcripts at
baseline, after ECS and after SD. Relative levels of individual Bdnf
transcripts in the mPFC of WT animals are reported at baseline (A),
after ECS (B) and after 12 h SD (C). Data in A, B and C are presented
as the fold change relative to levels of exon IV transcript levels in
each individual experiment (n = 4 each group).
Figure 4 Normal expression of GABAergic markers in BDNF-KIV
mice. Relative mRNA levels of markers of GABAergic interneurons in
mPFC of WT and BDNF-KIV were measured at baseline (Ctrl) and
after 12 h sleep deprivation (SD). Data is presented as fold change
over WT Ctrl for Gad1 (A), Pvalb (B), Calb1 (C) and Calb2 (D) (n = 3
each group).
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induced increase in exon I-driven transcription is signifi-
cantly attenuated in addition to the complete disruption
of promoter IV-driven activity, the BDNF-KIV mutant
animals provide a very useful tool for studying the
effects of activity-dependent BDNF expression on sleep
homeostasis and behavior.
BDNF has been implicated in the development and
function of the cortical inhibitory system at multiple
levels [16,43-45]. Several studies have suggested that
BDNF plays an important role in regulating inhibitory
interneuron migration in the cerebral cortex [46-48].
BDNF also plays a key role in inhibitory interneuron dif-
ferentiation and maintenance later in neurodevelopment
[16,43,45]. Substantial evidence has shown that BDNF
signaling through TrkB is critical in promoting inhibi-
tory interneuron synaptogenesis and development of a
mature GABAergic phenotype by inducing the expres-
sion of markers of GABAergic cells including GAD67,
GAT1, calcium-binding proteins including parvalbumin
as well as various neuropeptides [16,19,22,43,45]. Func-
tionally, the impact of BDNF signaling on promoting
maturation of cortical inhibition results in regulation of
the critical period for plasticity in the visual cortex [16].
The onset of the critical period for visual development
coincides with the initiation of non-REM sleep homeos-
tasis, and monocular deprivation experiments have
shown that sleep enhances synaptic remodeling during
the critical period of visual cortex development [49]. It
is of interest that the developmental induction of cortis-
tatin expression at the end of the second postnatal week
in rodent life coincides with rapidly rising cortical
BDNF levels, initiation of the critical period for visual
cortical plasticity, and onset of non-REM sleep
[16,25,49-51]. The present study demonstrates a role for
activity-dependent BDNF expr e s s i o ni nr e g u l a t i o no f
sleep behavior, possibly via effects on a subset of cortical
GABAergic interneurons. These results may have impli-
cations in critical period plasticity in visual cortex as
well as other cortical areas.
In the adult brain cortistatin expression is correlated
with sleep need and its administration promotes slow-
wave activity (SWA) [27,35]. Cort gene expression is
highest at the end of the circadian active period and
increases dramatically in response to SD [27,35]. Func-
tionally, it has been shown that intracerebroventricular
administration of cortistatin leads to induction of SWA
[27,35]. Interestingly, the increase in SWA observed
after SD only occurs in rats after postnatal day 20, coin-
ciding with the time when SD begins to induce cortical
Figure 5 Dysregulation of neuropeptide genes in subsets of GABAergic interneurons. Relative levels of neuropeptides in a subset of
GABAergic interneurons at baseline (Ctrl) and after 12 h sleep deprivation (SD) in WT and BDNF-KIV animals. Data is presented as fold change
over WT Ctrl for Npy (A), Sst (B), Cort (C), Tac1 (D) and Crhbp (E) (n = 3 each group).
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with electrophysiological maturation of the inhibitory
interneuron system and attainment of maximal slow
wave delta power [50,53].
It has been reported that enhancing BDNF expression
via exploratory activity during waking is causally linked to
homeostatic sleep mechanisms [9,10]. Some studies have
suggested that BDNF protein, which increases during sus-
tained waking, leads to heightened synaptic potentiation
and increased cell-to-cell coupling [6,7,9,10]. This in turn,
leads to increased cortical synchrony and, subsequently,
increased SWA power [6,7,9,10]. Our results suggest that
a subset of GABAergic interneurons expressing several
neuropeptide markers, including cortistatin, are highly
sensitive to activity-dependent BDNF signaling and sleep
pressure. Expression of Crhbp, a binding protein that acts
to sequester corticotropin releasing hormone (CRH) may
also define this subset of interneurons. Crhbp expression
is also misregulated in the BDNF-KIV mice, is induced fol-
lowing sleep deprivation, and has been co-localized with
NPY-positive interneurons [54]. Recent studies have
shown that CRH may also be capable of modulating sleep
homeostasis [55]. Future experiments should directly
examine whether regulation of sleep homeostasis by activ-
ity-dependent BDNF expression is mediated by this sub-
population of cortistatin-positive GABAergic interneurons.
Conclusions
I nc o n c l u s i o n ,w eh a v es h o w nt h a tag e n e t i cm a n i p u l a -
tion that disrupts activity-dependent BDNF expression
results in behavioral impairments that are consistent
with a deficit in sleep homeostasis. We also show that
this genetic alteration leads to a substantial misregula-
tion of Cort gene expression. Our results raise the possi-
bility that BDNF regulation of sleep behavior may, at
least in part, be mediated via activity-dependent BDNF
regulation of cortistatin-positive interneurons.
Methods
Animals
BDNF-KIV animals were generated as described pre-
viously [32], and further backcrossed onto a pure
C57Bl/6 background. Animalsw e r eh o u s e ds i n g l yf r o m
the time of weaning (21 d) and maintained in a reverse
light-dark housing room (lights on 21:00 and lights off
09:00) in standard housing cages with ad libitum food
and water. Procedures were conducted in accordance
with the National Institutes of Health guidelines and
approved by the NIH Institutional Animal Care and Use
Committee.
Electroconvulsive Shock (ECS)
ECS was delivered to mice under isoflurane inhalation
anesthesia via bilateral ear clip electrodes using an
Applegate Electronics ES3 unit. The stimulus current
w a s6 0m A ,6 0H z ,s i n ew a v eo f1sd u r a t i o n .T h ep r e -
sence of tonic seizures immediately after the shock was
confirmed by observing the extension of all limbs and
forward head extension that normally last for about
10-15 s in each cohort regardless of genotype. Mice were
returned to their cages 10 min following the procedure.
Sleep Deprivation
Total sleep deprivation (12 h) was carried out according
to previously described protocols [3,56]. Animals were
gently handled, frequently exposed to novel objects and
periodically changed to new cages. A single
Figure 6 Changes in sleep behavior due to disruption of
activity-dependent BDNF expression. (A). Total time over a 24 h
session spent sleeping by WT and BDNF KIV mice (n = 8 each
genotype). (B). Hour-by-hour plot of sleep behavior over the 24 h
period with lights off phase (1-12 h) indicated by shading. (C). Hour-
by-hour plot of sleep behavior under conditions of constant
darkness. Dark shaded area represents period of time corresponding
to animals’ original lights off, active phase. Arrows point to
conserved rest periods during the active phase in WT animals (n =
4 each genotype).
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the 12 h period. Mice were sleep deprived starting at
21:00 h and were continuously monitored throughout
the ensuing light period. Mice in the control groups
remained in their standard home caging.
HomeCage Monitoring
Sleep behavior was analyzed using automated home cage
monitoring for up to 48 h. Videos were captured within
a sound-attenuated, temperature controlled environment
with a constant white noise background designed by
KM and RJS and built by CleverSys using digital cam-
eras and CaptureStar software (CleverSys, Reston, VA).
Infrared lights were used for illumination during dark
phase recording. Automated video analysis of home
cage behavior was performed using HomeCageScan soft-
ware (CleverSys, Reston, VA). Behavior was detected by
utilizing information about the entire body of the ani-
mal, identifying animal body parts such as head, tail,
forelimbs, hind limbs, upper/lower back, abdomen, etc.,
and using the sequence data to automatically recognize
and analyze animal behavior in durations > 6 frames (30
frames/s).
RNA Extraction and cDNA conversion
Mice were quickly decapitated and brains rapidly
removed from the skull. Brains were cut into 3mm cor-
onal slices with the use of a brain block (Braintree
Scientific, Braintree MA) and submerged in RNALater
(Ambion). Slices remained in RNALater at 4°C for 3 d
before microdissection of the mPFC. After microdissec-
tion, tissues pieces were transferred to Trizol (Invitro-
gen, Carlsbad, CA) and dounce homogenized. Following
crude extraction, RNA was further purified on an
RNeasy Column with on-column DNase treatment
according to manufacturer’s instructions (Qiagen, Valen-
cia, CA). 0.5 ug of RNA was converted to cDNA using
Superscript III (Invitrogen) according to the manufac-
turer’s instructions.
Quantitative PCR
10ng of reverse transcribed cDNA was subsequently
used for each reaction with MGB FAM labeled TaqMan
probes (Applied Biosystems, Foster City, CA) in 1X
Gene Expression Master Mix (Applied Biosystems).
Sequences for exon-specific Bdnf probes were adapted
from previously published reports and ordered as cus-
tom TaqMan probes [57] (Applied Biosystems). Other
genes (G a d 1 ,C a l b 1 ,C a l b 2 ,P v a l b ,S s t ,N p y ,C o r t ,T a c 1 ,
Crhbp and Gapdh) were ordered as inventoried TaqMan
probes (Applied Biosystems). Each reaction was carried
out in triplicate on a 4S Realplex Mastercycler (Eppen-
dorf, Hamburg, Germany). PCR was carried out for 40
cycles of 95°C for 15 s and 60°C for 60 s. Relative
quantification of template was performed using the
ΔΔCt method with experimental cDNA data being nor-
malized to the control Gapdh level. Absolute quantifica-
tions for the ratios of of individual transcript abundance
was performed by extrapolating Ct value data to a stan-
dard curve, which was derived from serial dilution
amplifications with known amounts of plasmid DNA
containing the cloned sequence from PCR amplicons of
individual Bdnf transcripts.
BDNF ELISA
Mice were quickly decapitated and brains rapidly
removed from the skull. Brains were cut into 3mm coro-
nal slices with the use of a brain block and the mPFC was
further dissected with the aid of a dissecting microscope.
Tissue pieces were snap-frozen in an isopentane/dry-ice
bath and frozen at -80°C until processing. Tissue pieces
were dounced in lysis buffer (150mM NaCl, 10mM
Tris-Cl pH 7.2, 0.1% SDS, 1% Triton X-100, 1% Deoxy-
cholate and 5 mM EDTA), sonicated and further
extracted for 1 h with addition of 0.9% SDS. Protein
levels were normalized using a standard BCA assay
(Pierce) and then used for measurement of BDNF protein
levels with a commercial BDNF ELISA according to the
manufacturer’s instructions (Millipore, Billerica, MA).
Statistics
GraphPad Prism was used for all statistics including Stu-
dents t-test, one-way ANOVA with Newman-Keuls post
hoc analysis and two-way ANOVA. *p < 0.05, **p < 0.01
and ***p < 0.001.
Additional material
Additional file 1: Additional file 1. Table S1: “ANOVA table”
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BDNF: Brain-derived neurotrophic factor; CRH: corticotropin releasing
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